Pregnancy Registry Data Use In Labeling Should Be Compiled By FDA - PhRMA
Executive Summary
FDA should document the historical usefulness of pregnancy registry data to product labeling decisions before proceeding with its recently released pregnancy registry draft guidances, the Pharmaceutical Research & Manufacturers of America said in Aug. 31 comments to the agency.
You may also be interested in...
Pregnancy Registries May Use External Comparison Groups – Final Guidance
Pregnancy exposure registries may use external comparison groups, including background rates, surveillance systems and other registries, FDA said in its 1pregnancy registry final guidance
Pregnancy Registries May Use External Comparison Groups – Final Guidance
Pregnancy exposure registries may use external comparison groups, including background rates, surveillance systems and other registries, FDA said in its 1pregnancy registry final guidance
Follow-Up Data Should Be Component Of Pregnancy Registry Design - Cmte.
Pregnancy registries should be designed to allow for collection of longer-term follow-up data, members of the Pediatric Labeling Subcommittee suggested March 28.